Submit Deal

OXIPROTEOMICS

HQ - Paris

Summary

OxiProteomics is a company specializing in the discovery of biomarkers related to aging, age-related diseases and oxidative stress in biological samples.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Martin Baraibar
CEO

Sort

09 Sep 2025|France|Biotechnology

Target: OXIPROTEOMICS

Bidder: QIMA

3 Service Providers

1 Target | 2 Bidder

5 Dealmakers

1 Target | 4 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy